Effects of amphetamine and cocaine treatment on c-fos, Jun-B, and Krox- 24 expression in rats with intrastriatal dopaminergic grafts

Experimental Neurology

Volumn 159, Issue 1, 1999, Pages 139-152

  Rodriguez, J J ^a   Montaron, M F ^a   Aurousseau, C ^a   Le Moal, M ^a   Abrous, D N ^a  

^a INSERM   (France)

Author keywords

C Fos; Dopaminergic grafts; IEGs; Immunohistochemistry; Jun B; Krox 24; Neostriatum; Rotation

Indexed keywords

AMPHETAMINE; COCAINE; PROTEIN C FOS; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOREACTIVITY; MALE; NEOSTRIATUM; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

EID: 0032846029     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7129     Document Type: Article

References (60)

1. Abrous D. N., Guy J., Vigny A., Calas A., Le Moal M., Herman J. P. Development of intracerebral dopaminergic grafts: A combined immunohistochemical and autoradiographic study of its time course and environmental influences. J. Comp. Neurol. 273:1988;26-41.
2. Abrous D. N., Stinus L., Le Moal M., Herman J. P. Locomotor hyperresponse to intra-accumbens d-Ala-Met-enkephalin following the lesion of the mesocorticolimbic dopaminergic pathway: Reversal by intra-accumbens implants of embryonic dopaminergic neurones. Brain Res. 525:1990;155-159.
3. Abrous D. N., Torres E. M., Annett L. E., Reading P., Dunnett S. B. Intrastriatal dopaminergic-rich grafts induce a hyperexpression of Fos protein when challenged with amphetamine. Exp. Brain Res. 91:1992;181-190.
4. Abrous D. N., Choulli K., Rougé-Pont F., Simon H., Le Moal M., Herman J. P. Effects of intracerebral dopaminergic grafts on behavioural deficits induced by neonatal 6-OHDA lesions of the meso-telencephalic dopaminergic pathway. Neuroscience. 54:1993;499-511.
5. Abrous D. N., Bernard V., Bloch B., Le Moal M., Herman J. P. Identity of striatal cells expressing abnormally c-fos following amphetamine treatment to rats with intrastriatal dopaminergic grafts. Eur. J. Neurosci. 8:1996;2521-2529.
6. Abrous D. N., Desjardins S., Sorin B., Le Moal M., Herman J. P. Changes in striatal immediate-early gene expression following neonatal dopaminergic lesion and effects of intrastriatal dopaminergic transplants. Neuroscience. 73:1996;145-159.
7. Alexander G. E., Crutcher M. D. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. TINS. 13:1990;266-271.
8. Annett L. E., Reading P. J., Tharumaratnam D., Abrous D. N., Torres E. M., Dunnett S. B. Conditioning versus priming of dopaminergic grafts by amphetamine. Exp. Brain Res. 93:1993;46-54.
9. Bal A., Savasta M., Chritin M., Mennicken F., Abrous D. N., Le Moal M., Feuerstein C., Herman J. P. Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic nigrostriatal pathway: A quantitative in situ hybridization study. Mol. Brain Res. 18:1993;221-227.
10. Berretta S., Robertson H. A., Graybiel A. M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like-protein in the striatum. J. Neurophysiol. 68:1992;767-777.
11. R. Bhat, Baraban J. M. Activation of transcription factor genes in striatum by cocaine: Role of both serotonin and dopamine systems. J. Exp. Pharmacol. Exp. Ther. 267:1993;496-505.
12. Björklund A., Dunnett S. B., Stenevi U., Lewis M. E., Iversen S. D. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199:1980;307-333.
13. Bronstein D. M., Ye H., Pennypacker K. R., Hudson P. M., Hong J.-S. Role of a 35kDa FRA in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Mol. Brain Res. 23:1994;191-203.
14. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;656-661.
15. Cadoni C., Pinna A., Russi G., Consolo S., Di Chiarra G. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: Evidence from microdialysis and Fos immunohistochemistry. Neuroscience. 65:1995;1027-1039.
16. Cenci M. A., Campbell K., Wictorin K., Björklund A. Striatal c-fos induction by cocaine of apomorphine occurs preferentially in output neurones projecting to the substantia nigra in the rat. Eur. J. Neurosci. 4:1992;376-380.
17. Cenci M. A., Kalen P., Mandel R. J., Wictorin K., Björklund A. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience. 46:1992;943-958.
18. Cenci M. A., Björklund A. Transection of cortico-striatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich graft when challenged with amphetamine. Brain Res. 665:1994;167-174.
19. 1 dopamine receptor activation of multiple transcription factors genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
20. Desjardins S., Mayo W., Vallée M., Hancock D., Le Moal M., Simon H., Abrous D. N. Effect of ageing on the basal expression of c-Fos, c-Jun and Egr-1 proteins in the hippocampus. Neurobiol. Aging. 18:1997;37-44.
21. Dragunow M., Lawlor P., Chiasson B., Robertson H. C-fos antisense generates apomorphine and amphetamine-induced roation. NeuroReport. 5:1993;1305-1306.
22. Dragunow M., Butterworth N., Waldfovgel H., Faull R. L. M., Nicholson L. F. B. Prolonged expression of Fos-related antigens, JunB and TrkB in dopamine-denervated striatal neurones. Mol. Brain Res. 30:1995;393-396.
23. Dunnett S. B., Björklund A., Schmidt R. H., Stenevi U., Iversen S. D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. 522:1983;29-37.
24. Dunnett S. B., Whishaw I. Q., Jones G. H., Isacson O. Effects of dopamine-rich grafts on conditioned rotations in rats with unilateral 6-hydroxydopamine lesions. Neurosci. Lett. 68:1986;127-133.
25. Freund T. F., Bolam J. P., Björklund A., Stenevi U., Dunnett S. B., Powell J. F., Smith J. D. Efferent synaptic connections of grafted dopaminergic neurones reinnervating the host neostriatum: A tyrosine hydroxylase immunocytochemical study. J. Neurosci. 5:1985;603-616.
26. Gass P., Herdegen T., Bravo R., Kiessling M. Induction of immediate early gene encoded proteins in rat hippocampus after bicuculline-induced seizures: Differential expression of Krox 24, Fos and Jun proteins. Neuroscience. 48:1992;315-324.
27. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurones. Science. 250:1990;1429-1432.
28. Graybiel A. M., Moratalla R., Robertson H. A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
29. Heilig M., Engel J., Soderpalm B. C-fos antisense in the nucleus accumbens blocks the locomotor stimulation of cocaine. Eur. J. Neurosci. 236:1993;339-340.
30. Herman J. P., Choulli K., Le Moal M. Hyper-reactivity to amphetamine in rats with dopaminergic grafts. Exp. Brain Res. 60:1985;521-526.
31. Herman J. P., Choulli K., Abrous D. N., Dulluc J., Le Moal M. Effects of intra-accumbens grafts on behavioral deficits induced by 6-OHDA lesions of the nucleus accumbens or A10 dopaminergic neurones: a comparison. Behav. Brain Res. 29:1988;73-83.
32. Herman J. P., Abrous D. N., Le Moal M. Anatomical and behavioral comparison of unilateral dopamine-rich grafts implanted into the striatum of neonatal and adult rats. Neuroscience. 40:1991;465-475.
33. Herman J. P., Rougé-Pont F., Le Moal M., Abrous D. N. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurones: An pharmacological and biochemical analysis. Neuroscience. 53:1993;1083-1095.
34. Herman J. P., Abrous D. N. Dopaminergic neural grafts after fifteen years: Results and perspectives. Prog. Neurobiol. 44:1994;1-35.
35. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47:1995;133-178.
36. Johansson B., Lindström K., Fredholm B. B. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience. 59:1994;837-849.
37. Kuczenski R., Segal D. S., Aizenstein M. L. Amphetamine, cocaine and fencamfamine: Relationship between locomotor and sterotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11:1991;2703-2712.
38. Kovary K., Bravo R. Existence of different Fos/Jun complexes during Go-to-Gi transition and during exponant growth in the mopouse fibroblasts: Differential role of Fos proteins. Mol. Cell Biol. 12:1992;5015-5023.
39. Mackler S. A., Eberwine J. H. The molecular biology of addictive drugs. Mol. Neurobiol. 5:1991;45-58.
40. Mailleux P., Zhang F., Vanderhaeghen J.-J. The dopamine D1 receptor antagonist SCH-23390 decreases the mRNA levels of the transcription factor krox 24 in adult rat intact striatum: An in situ hybridization study. Neurosci. Lett. 147:1992;182-184.
41. Manier M., Abrous D. N., Feuerstein C., Le Moal M., Herman J. P. Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurones: A quantitative immunohistochemical analysis. Neuroscience. 42:1991;427-439.
42. Merchant K. M., Dorsa D. M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. USA. 90:1993;3447-3451.
43. Miller R., Beninger R. J. On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine. Prog. Neurobiol. 36:1991;29-256.
44. Moratalla R., Robertson H. A., Graybiel A. M. Dynamic regulation of NGFI-A (Zif 268, egr 1 gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
45. Moratalla R., Vickers E. A., Robertson H. A., Cochran B. H., Graybiel A. M. Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine. J. Neurosci. 13:1993;423-433.
46. 2 receptors. Brain Res. 623:1993;334-336.
47. Nguyen T. V., Kosofsky B. E., Birnbaum R., Cohen B. M., Hyman S. E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine and amphetamine. Proc. Natl. Acad. Sci. USA. 89:1992;4270-4274.
48. Paul M. L., Graybiel A. M., David J.-C., Robertson H. A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
49. Pellegrino L. J., Pellegrino A. S., Cushman A. J. A Stereotoxic Atlas of the Rat Brain. 1967;Plenum.
50. Pollack A. E., Fink J. S. Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience. 68:1995;721-728.
51. 14C]2-deoxy-d-glucose autoradiography. J. Neurochem. 38:1982;737-748.
52. Sylvia C. P., Jaber M., King G. R., Ellinwood E. H., Caron M. G. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience. 76:1997;737-747.
53. Sommer W., Bejlke B., Ganten D., Fuxe K. Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour to d-amphetamine. NeuroReport. 5:1993;277-280.
54. Snyder-Keller A. M. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113:1991;155-165.
55. Strecker R. E., Sharp T., Brundin P., Zetterstöm T., Ungerstedt U., Björklund A. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intrastriatal dialysis. Neuroscience. 22:1987;169-178.
56. Wang J. Q., Smith A. J. W., McGinty J. F. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and predynorphin messenger RNA expression in rat forebrain. Neuroscience. 68:1995;83-95.
57. Young S. T., Porrino L. J., Iadarola M. J. Cocaine induces striatal c-Fos immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA. 88:1991;1291-1295.
58. Zetterström T., Brundin P., Gage F. H., Sharp T., Isacson O., Dunnett S. B., Ungestedt U., Björklund A. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal grafts using intracerebral dialysis. Brain Res. 362:1986;344-349.
59. Zetterström T., Sharp T., Marsden C. A., Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: Changes after d-amphetamine. J. Neurochem. 41:1983;1769-1773.
60. Zhang W. Q., Pennypacker K. R., Merchenthaler J. J., Grimes L., Iadorola M. J., Hong J. S. A 35kDA Fos related antigen is co-localized with substance P and dynorphin in striatal neurones. Brain Res. 577:1992;312-317.